FDA NDC Directory · JSON-LD · Markdown

Lovastatin

NDC 68001-315 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namelovastatin
Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA078296
Dosage form / routeTABLET · ORAL
Active ingredientsLOVASTATIN (20 mg/1)
Marketing started20071101
Package count2

External sources

Source: openFDA. Public-domain (CC0).